Abstract:Estrogens have complex effects on the skeleton, including regulation of modeling and maintenance of bonemass, which vary with cell type and developmental stage. Osteoblasts are key regulators of skeletal matrix synthesis and degradation. However, whether osteocytes, osteoblasts or earlier progenitors mediate estrogen effects, and the importance of estrogen receptors (ERs) alpha and beta, remain unclear. To address estrogen response in human cells closely related to secretory osteoblasts, we studied MG63 cells with ERalpha or ERbeta reduced to low levels by stable transfection of antisense plasmids. Collagen and alkaline phosphatase expression increased with estrogen in wild-type and ERalpha-suppressed cells, but not in ERbeta-suppressed cells. Matrix secretion occurs as osteoblasts cease dividing, and, in keeping with this, cell proliferation was reduced by estrogen except in ERbeta-antisense cells. No effects of estrogen on wild type or ER-suppressed cells were seen in expression of BMP 2, the BMP antagonist noggin, or Indian hedgehog, products that regulate differentiation of osteoblasts. In contrast to expectations that estrogen would modulate bone degradation, RANKL, CSF-1, and osteoprotegerin did not respond measurably to estrogen, regardless of ER status. In keeping with this result, estrogen response was not observed in assays of osteoclast development from CD14 cells supported by wild-type or ER-silenced MG63 cells. Since estrogens are major regulators of bone degradation in vivo, estrogen effects on osteoclasts may depend on interaction with stimuli present in bone but absent in the model studied. cDNA hybridization showed that additional estrogen-binding proteins including ERRalpha and BCAR3 were expressed by MG63, but estrogen effects in ERbeta-silenced cells were small, so these proteins are either minor regulators in MG63 cells, or act in concert with stimuli in addition to estrogen. We conclude that, in the MG63 cell line, estrogen increases synthesis of matrix proteins via ERbeta, and that, in the absence of additional stimuli, these cells are not major mediators of estrogen effects on osteoclast differentiation. Further, ERalpha is probably much more important in earlier stages of skeletal development, such as growth plate response, than in osteoblasts. (C) 2003 Wiley-Liss, Inc.

The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells

Genistein promotion of osteogenic differentiation through BMP2/SMAD5/RUNX2 signaling.

Effects of Genistein, Daidzein and Glycitein on the Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells and on the Adipogenic Trans-Differentiation of Osteoblasts

The isoflavone genistein enhances osteoblastogenesis: signaling pathways involved

Genistein Regulates Murine Osteoblasts and Osteoclasts via Receptor-Mediated Pathway

[Effects of Genistein on Cell Proliferation and Differentiation in Human Osteoblast].

Inhibition of adipocyte differentiation by phytoestrogen genistein through a potential downregulation of extracellular signal-regulated kinases 1/2 activity.

Phytoestrogen Genistein Induces Osteoblastic Differentiation of Mouse Bone Marrow-Derived Mesenchymal Stem Cells Through P38 MAPK

[Effect of Genistein on the Proliferation, Differentiation and Apoptosis of the Osteoblasts].

Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrow culture.

Effect and mechanism of genistein on the proliferation of MC3T3-E1 cells

8-prenylgenistein exerts osteogenic effects via ER α and Wnt-dependent signaling pathway

Genistein Prevents Bone Resorption Diseases by Inhibiting Bone Resorption and Stimulating Bone Formation.

Effects of 17Β-Estradiol on Osteogenic and Adipogenic Differentiation of Bone Marrow Stromal Cells and Adipocytic Trans-Differentiation of Osteoblasts

Genistein Inhibits Osteoclastic Differentiation of RAW 264.7 Cells via Regulation of ROS Production and Scavenging

Effects of Genistein on Changes of Osteoblastic Biological Function Induced by Breast Cancer Cells

Effect of genistein on osteoclastic bone resorption and its mechanism

Bone action of the phytoestrogen genistein under hypoestrogenism and obesity

Effects of 17 beta-estradiol on osteogenic differentiation of rat primary cultured bone marrow mesenchymal stem cells

Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.

Effects of estriol on the proliferation and differentiation of human osteoblastic MG-63 cells